-
1
-
-
33646010024
-
Correlation between Bcl-2 and Bax in atrophic and hypertrophic type of actinic keratosis
-
Tomas D, Kruslin B, Cupic H, Stanimirovic A, Bosnjak B, Lovricevic I, et al. Correlation between Bcl-2 and Bax in atrophic and hypertrophic type of actinic keratosis. J Eur Acad Dermatol Venereol 2006;20:51-7.
-
(2006)
J Eur Acad Dermatol Venereol
, vol.20
, pp. 51-57
-
-
Tomas, D.1
Kruslin, B.2
Cupic, H.3
Stanimirovic, A.4
Bosnjak, B.5
Lovricevic, I.6
-
2
-
-
33644674793
-
New histopathological classification of actinic keratosis (incipient intraepidermal squamous cell carcinoma)
-
Cockerell CJ, Wharton JR. New histopathological classification of actinic keratosis (incipient intraepidermal squamous cell carcinoma). J Drugs Dermatol 2005;4:462-7.
-
(2005)
J Drugs Dermatol
, vol.4
, pp. 462-467
-
-
Cockerell, C.J.1
Wharton, J.R.2
-
3
-
-
3242715866
-
The development of actinic keratosis into invasive squamous cell carcinoma: Evidence and evolving classification schemes
-
Anwar J, Wrone DA, Kimyai-Asadi A, Alam M. The development of actinic keratosis into invasive squamous cell carcinoma: Evidence and evolving classification schemes. Clin Dermatol 2004;22:189-96.
-
(2004)
Clin Dermatol
, vol.22
, pp. 189-196
-
-
Anwar, J.1
Wrone, D.A.2
Kimyai-Asadi, A.3
Alam, M.4
-
4
-
-
0034220016
-
Actinic keratosis is squamous cell carcinoma
-
Lober BA, Lober CW. Actinic keratosis is squamous cell carcinoma. South Med J 2000;93:650-5.
-
(2000)
South Med J
, vol.93
, pp. 650-655
-
-
Lober, B.A.1
Lober, C.W.2
-
5
-
-
84944478475
-
Early epidermal neoplasia: Description and interpretation - The theory of mutation in the origin of cancer
-
Sutton RL Jr. Early epidermal neoplasia: Description and interpretation-The theory of mutation in the origin of cancer. Arch Derm Syphil 1938;37:737-80.
-
(1938)
Arch Derm Syphil
, vol.37
, pp. 737-780
-
-
Sutton Jr., R.L.1
-
6
-
-
33750078773
-
Early cutaneous carcinoma
-
Sutton RL Jr. Early cutaneous carcinoma. J Am Med Assoc 1935;104:433-9.
-
(1935)
J Am Med Assoc
, vol.104
, pp. 433-439
-
-
Sutton Jr., R.L.1
-
7
-
-
33750076446
-
Solar keratosis?
-
Ackerman B, Mones JM, editors. Ardor Scribiendi: New York
-
nd ed. Ardor Scribiendi: New York; 2001. p. 341-50.
-
(2001)
nd Ed.
, pp. 341-350
-
-
Ackerman, B.1
Mones, J.M.2
-
8
-
-
0347750727
-
Solar keratosis with 'Darier-like features' is 'pseudoglandular' squamous-cell carcinoma
-
Javier BJ, Ackerman AB. Solar keratosis with 'Darier-like features' is 'pseudoglandular' squamous-cell carcinoma. Dermatopathol Pract Concept 2000;6:114-21.
-
(2000)
Dermatopathol Pract Concept
, vol.6
, pp. 114-121
-
-
Javier, B.J.1
Ackerman, A.B.2
-
9
-
-
0033936811
-
The nature of solar keratosis: A critical review in historical perspective
-
Heaphy MR Jr, Ackerman AB. The nature of solar keratosis: A critical review in historical perspective. J Am Acad Dermatol 2000;43:138-50.
-
(2000)
J Am Acad Dermatol
, vol.43
, pp. 138-150
-
-
Heaphy Jr., M.R.1
Ackerman, A.B.2
-
10
-
-
0033910316
-
Squamous-cell carcinoma, not basal-cell carcinoma, is the most common cancer in humans
-
Brand D, Ackerman AB. Squamous-cell carcinoma, not basal-cell carcinoma, is the most common cancer in humans. J Am Acad Dermatol 2000;42:523-6.
-
(2000)
J Am Acad Dermatol
, vol.42
, pp. 523-526
-
-
Brand, D.1
Ackerman, A.B.2
-
13
-
-
0019826126
-
Topical chemotherapy with 5-fluorouracil. A review
-
Goette DK. Topical chemotherapy with 5-fluorouracil. A review. J Am Acad Dermatol 1981;4:633-49.
-
(1981)
J Am Acad Dermatol
, vol.4
, pp. 633-649
-
-
Goette, D.K.1
-
14
-
-
0031054947
-
Chemotherapy for disseminated actinic keratoses with 5-fluorouracil and isotretinoin
-
Sander CA, Pfeiffer C, Kligman AM, Plewig G. Chemotherapy for disseminated actinic keratoses with 5-fluorouracil and isotretinoin. J Am Acad Dermatol 1997;36:236-8.
-
(1997)
J Am Acad Dermatol
, vol.36
, pp. 236-238
-
-
Sander, C.A.1
Pfeiffer, C.2
Kligman, A.M.3
Plewig, G.4
-
15
-
-
0035659622
-
Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses
-
Wolf JE Jr, Taylor JR, Tschen E, Kang S. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol 2001;40:709-13.
-
(2001)
Int J Dermatol
, vol.40
, pp. 709-713
-
-
Wolf Jr., J.E.1
Taylor, J.R.2
Tschen, E.3
Kang, S.4
-
16
-
-
1342311511
-
Topical 3% diclofenac in 2.5% hyaluronan gel for the treatment of actinic keratoses
-
Rivers JK. Topical 3% diclofenac in 2.5% hyaluronan gel for the treatment of actinic keratoses. Skin Therapy Lett 2004;9:1-3.
-
(2004)
Skin Therapy Lett
, vol.9
, pp. 1-3
-
-
Rivers, J.K.1
-
17
-
-
33750091315
-
Efficacy of 3% diclofenac gel for treatment of actinic keratoses
-
Fariba I, Ali A, Hossein SA, Atefeh S, Behbahan AZ, Afshin S. Efficacy of 3% diclofenac gel for treatment of actinic keratoses. Indian J Dermatol Venerol Leprol 2006;72:346-9.
-
(2006)
Indian J Dermatol Venerol Leprol
, vol.72
, pp. 346-349
-
-
Fariba, I.1
Ali, A.2
Hossein, S.A.3
Atefeh, S.4
Behbahan, A.Z.5
Afshin, S.6
-
18
-
-
0041920772
-
Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod
-
Schon M, Bong AB, Drewnick C, Herz J, Geilen CC, Reifenberger J, et al. Tumor-selective Induction of apoptosis and the small-molecule immune response modifier imiquimod. J Natl Canc Inst 2003;95:1138-49.
-
(2003)
J Natl Canc Inst
, vol.95
, pp. 1138-1149
-
-
Schon, M.1
Bong, A.B.2
Drewnick, C.3
Herz, J.4
Geilen, C.C.5
Reifenberger, J.6
|